Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Etiprednol dicloacetate (BNP-166) is a corticosteroid with anti-inflammatory activity.Etiprednol dicloacetate inhibits the accumulation of eosinophils and can be used in the study of inflammatory airway diseases such as asthma and in the treatment of Crohn's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 112.00 | |
5 mg | In stock | $ 260.00 | |
10 mg | In stock | $ 390.00 | |
25 mg | In stock | $ 653.00 | |
50 mg | In stock | $ 928.00 | |
100 mg | In stock | $ 1,260.00 |
Description | Etiprednol dicloacetate (BNP-166) is a corticosteroid with anti-inflammatory activity.Etiprednol dicloacetate inhibits the accumulation of eosinophils and can be used in the study of inflammatory airway diseases such as asthma and in the treatment of Crohn's disease. |
In vitro | Etiprednol dicloacetate (1 nM-1 μM) Inhibition of LPS-induced TNF-α production in human blood.[1] |
In vivo |
Etiprednol dicloacetate (0-100 μg/kg; intranasal inhalation) reduces peribronchial eosinophilia in the lungs of allergen-sensitized and challenged rats.[1] Etiprednol dicloacetate (0-20 mg/kg; p.o.; 28 days) is well tolerated in rats and dogs.[2] Etiprednol dicloacetate (0.1 μg/kg; intranasal inhalation) inhibits eosinophil accumulation in rats (eosinophilic infiltration induced by antigen exposure).[3] |
Synonyms | BNP 166, BNP166, BNP-166 |
Molecular Weight | 485.4 |
Formula | C24H30Cl2O6 |
CAS No. | 199331-40-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (113.31 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Etiprednol dicloacetate 199331-40-3 Others BNP 166 BNP166 BNP-166 inhibitor inhibit